Stress, depression linked to MCI, Alzheimer’s disease
Oct 20, 2023
Chronic stress and depression are independent risk factors and have an additive effect when combined.
Thyrotoxicosis linked to risk for incident cognitive disorder
Dec 28, 2023
Exogenous thyrotoxicosis remained a significant risk factor for cognitive disorders when stratified by cause and severity.
Lower cutoff points for Montreal cognitive assessment needed
Jan 17, 2024
A high false-positive rate was seen when used in primary care with a diverse patient population.
Timing of CSF biomarker divergence for Alzheimer’s disease, normal cognition varies
Feb 21, 2024
Estimated times of divergence of cerebrospinal fluid biomarkers vary from 18 years for Aβ42 to six years for cognitive decline.
Self-, partner-reported cognitive decline linked to tau
May 30, 2024
Significant associations were seen between self- and study partner-reported Cognitive Function Index and tau driven by elevated Aβ.
Facility staff and families both struggle to figure out processes for dementia patients, report reveals
By
Kimberly Bonvissuto
Mar 20, 2024
It’s not just family caregivers who face challenges navigating dementia care — the nation’s healthcare workers also said they had difficulties providing care coordination through a complex healthcare...
Exposure to depressive symptoms linked to worse cognitive function
Jun 12, 2024
Prolonged exposure beginning in young adulthood linked to worse cognitive function over midlife, especially among Blacks
Tau PET performs well in predicting dementia in individuals with MCI
Jun 12, 2024
Tau positron emission tomography predicts all-cause dementia and Alzheimer disease dementia
Monoclonal antibodies provide small benefits in Alzheimer’s disease
Jan 26, 2024
Harms include increased risks for amyloid-related imaging abnormalities (ARIA)-edema, ARIA-hemorrhage and symptomatic ARIA-edema.
Lifestyle intervention can improve cognition, function in early Alzheimer’s disease
Jun 13, 2024
A significant correlation was seen between lifestyle and both cognitive function and Aβ42/40 ratio.